Finding 635749 (2022-002)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-03-29

AI Summary

  • Core Issue: The Medical Center failed to document the review and approval of compliance and financial reports before submission to the Department of Health and Human Services.
  • Impacted Requirements: This violates 2 CFR 200.303(a), which mandates effective internal controls over federal awards.
  • Recommended Follow-Up: Enhance internal control policies to ensure formal documentation of review and approval is consistently obtained and retained.

Finding Text

2022-002 Department of Health and Human Services Federal Financial Assistance Listing/CFDA #93.332 Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges Reporting Significant Deficiency in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition: There was no evidence retained that the Medical Center?s compliance and financial reports submitted to the Department of Health and Human Services were reviewed and approved prior to submission. Cause: The Medical Center did not have an internal control policy in place to ensure documented review and approval of the compliance and financial reports. Effect: The lack of adequate policies governing review and approval increases the risk that employees participating in the federal awards administration may not be able to detect and correct noncompliance in a timely manner. Questioned Costs: None reported. Context: A nonstatistical sample of 13 out of 72 reports were selected for detail testing and did not include evidence of a review by someone other than the preparer. Repeat Finding from Prior Years: No Recommendation: We recommend that the Medical Center enhance internal control policies to ensure that formal documentation of review and approval is obtained and retained. Views of Responsible Officials: Management agrees with the finding.

Categories

Reporting Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 59306 2022-001
    Significant Deficiency
  • 59307 2022-002
    Significant Deficiency
  • 635748 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $4.33M
93.461 Covid-19 Testing for the Uninsured $2.88M
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated and State Partnership Marketplaces $951,063
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $369,465
16.575 Crime Victim Assistance $203,632
16.838 Comprehensive Opioid Abuse Site-Based Program $168,352
93.959 Block Grants for Prevention and Treatment of Substance Abuse $158,463
32.006 Covid-19 Telehealth Program $109,859
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $96,725
93.788 Opioid Str $83,388
93.387 National and State Tobacco Control Program (b) $16,924
93.969 Pphf Geriatric Education Centers $13,126
93.516 Affordable Care Act (aca) Public Health Training Centers Program $10,000